Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities

BACKGROUND: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Recently, the 2019 novel coronavirus (COVID-19) pandemic has shined a spotlight on CLIA-waived diagnostic te...

Descripción completa

Detalles Bibliográficos
Autores principales: Klepser, Nicklas S., Klepser, Donald G., Adams, Jennifer L., Adams, Alex J., Klepser, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737532/
https://www.ncbi.nlm.nih.gov/pubmed/33342702
http://dx.doi.org/10.1016/j.sapharm.2020.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737532/
https://www.ncbi.nlm.nih.gov/pubmed/33342702
http://dx.doi.org/10.1016/j.sapharm.2020.12.003

Ejemplares similares